Accrol Group Holdings PLC Notice of Results and Online Investor Presentation (3570E)
July 07 2021 - 1:00AM
UK Regulatory
TIDMACRL
RNS Number : 3570E
Accrol Group Holdings PLC
07 July 2021
7 July 2021
ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")
AIM: ACRL
Notice of Results and Online Investor Presentation
Accrol Group, one of the UK's leading independent tissue
converters, announces that it will release its Final Results for
the year ended 30 April 2021 on Wednesday, 14 July 2021.
An analyst briefing will be held online at 9.00 am on that day.
Equity analysts interested in joining the meeting should contact
Belvedere Communications, see details below.
As part of the Group's Final Results roadshow, the management
will host an online investor presentation and Q&A session. This
will take place on Thursday, 15 July 2021 at 1.15pm. Anyone wishing
to participate should register for the event with PI World at:
https://bit.ly/ACRL_FY21_webinar.
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser
& Broker)
Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512
Dominic King / John Goold Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker) Tel: +44 (0) 20 3100 2222
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine Tel: +44 (0) 7715 769 078
Keeley Clarke Tel: +44 (0) 7967 816 525
accrolpr@belvederepr.com
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and
supplier of toilet tissues, kitchen rolls and facial tissues to
many of the UK's leading discounters and grocery retailers across
the UK. Following the recent acquisition of a state-of-the-art
tissue converter based in Leicester, the Group now operates from
five sites, including four in Lancashire, which generate revenues
totalling c.16% of the GBP1.7bn UK retail tissue market.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORUPUBPMUPGGAQ
(END) Dow Jones Newswires
July 07, 2021 02:00 ET (06:00 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2023 to Apr 2024